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Abstract
Yersinia pseudotuberculosis is a foodborne pathogen that subverts immune function by
translocation of Yersinia outer protein (Yop) effectors into host cells. As adaptive γδ T cells
protect the intestinal mucosa from pathogen invasion, we assessed whether Y. pseudotuberculosis subverts these cells in mice and humans. Tracking Yop translocation revealed
that the preferential delivery of Yop effectors directly into murine Vγ4 and human Vδ2+ T
cells inhibited anti-microbial IFNγ production. Subversion was mediated by the adhesin
YadA, injectisome component YopB, and translocated YopJ effector. A broad anti-pathogen
gene signature and STAT4 phosphorylation levels were inhibited by translocated YopJ.
Thus, Y. pseudotuberculosis attachment and translocation of YopJ directly into adaptive γδ
T cells is a major mechanism of immune subversion in mice and humans. This study uncovered a conserved Y. pseudotuberculosis pathway that subverts adaptive γδ T cell function
to promote pathogenicity.

Author summary
Unconventional γδ T cells are a dynamic immune population important for mucosal protection of the intestine against invading pathogens. We determined that the foodborne
pathogen Y. pseudotuberculosis preferentially targets an adaptive subset of these cells to
subvert immune function. We found that direct injection of Yersinia outer proteins (Yop)
into adaptive γδ T cells inhibited their anti-pathogen functions. We screened all Yop effectors and identified YopJ as the sole effector to inhibit adaptive γδ T cell production of
IFNγ. We determined that adaptive γδ T cell subversion occurred by limiting activation of
the transcription factor STAT4. When we infected mice with Y. pseudotuberculosis
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expressing an inactive YopJ, this enhanced the adaptive γδ T cell response and led to
greater cytokine production from this subset of cells to aid mouse recovery. This mechanism of immune evasion appears conserved in humans as direct injection of Y. pseudotuberculosis YopJ into human γδ T cells inhibited cytokine production. This suggested to us
that Y. pseudotuberculosis actively inhibits the adaptive γδ T cell response through YopJ as
a mechanism to evade immune surveillance at the site of pathogen invasion.

Introduction
Pathogens in the genus Yersinia include three species (Y. pestis, Y. pseudotuberculosis, and Y.
enterocolitica) that can cause human disease. Y. pseudotuberculosis and Y. enterocolitica cause
enteric infections [1,2] while Y. pestis is the causative agent of bubonic, septicemic, and pneumonic plague that has claimed over 200 million human lives [3,4]. Bubonic and septicemic
plague is transmitted by blood sucking fleas while aerosols spread the pneumonic plague.
Despite vaccine availability [5], and sensitivity to antibiotic treatment, pneumonic plague commonly results in fatality in part due to the rapid course of the infection [6].
Pathogenic Yersinia spp. harbor a virulence plasmid that encodes numerous virulence factors to subvert host immune responses, including IFNγ production [7–9]. Immune cell subversion requires Yersinia adherence to host cells through bacterial adhesins and translocation of
Yersinia outer proteins (Yop) effectors into the host cell cytoplasm by a type III secretion system (T3SS). Yersinia spp. predominately target host phagocytes like macrophages, dendritic
cells (DC), neutrophils, and B cells to subvert immune function during infection, but injection
into other immune populations like conventional T cells has been reported, albeit to a lesser
degree than their phagocytic counterparts [10–12]. Yersinia virulence factors include components of the T3SS (e.g., YopB) and translocated effectors (e.g., YopJ and YopH). YopB forms a
pore in the host cell membrane necessary for translocation of Yop effectors [13,14]. Numerous
Yop effectors translocate into host cells to inhibit immune responses and promote Yersinia
spp. pathogenesis. One notable example is YopJ, an acetyl transferase and a possible cysteine
protease that inhibits the mitogen-activated protein kinase (MAPK) pathway and tumor
necrosis factor receptor-associated factor (TRAF) ubiquitination [15–19]. YopJ is the major
Yop effector responsible for the induction of pyroptosis in macrophages during infection [20]
and limits toll-like receptor 4 (TLR4) dependent signaling pathways [21]. While YopJ has no
known direct effects on conventional T cell activation, YopP (a YopJ homolog in Y. enterocolitica) indirectly inhibits T cell priming via DC subversion [22]. YopH has been reported to
have direct effects on conventional T cells in vitro. Transfection of a YopH expression plasmid
into Jurkat or human T cells inhibited T cell receptor (TCR) signaling and promoted T cell
apoptosis [23,24]. Additionally, stimulation of Jurkat cells with a YopH deficient Y. pseudotuberculosis restored T cell signaling and IL-2 production [25,26]. Even in this context, it is notable that many of the downstream targets in the αβ TCR signaling pathway were inhibited at an
excessively high (>50) multiplicity of infection (MOI) and in vivo relevance is unclear [23,26].
Thus, the role of direct subversion of T cell function, especially among unconventional T cells,
by Yersinia spp. remains largely unexplored.
γδ T cells make up a large proportion of lymphocytes at barrier surfaces and mucosal tissues
including the intestines of mice and humans [27,28]. This is particularly pertinent to infections
caused by Y. pseudotuberculosis, which has evolved to invade the intestinal barrier. The activity
of γδ T cells can be modulated by numerous cell-intrinsic and environmental factors like the
γδ TCR, cytokines, and co-stimulatory or inhibitory receptors [29]. For example, IL-12 and
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IL-18 may promote IFNγ production from some γδ T cell subsets whereas IL-1β and IL-23
predominantly drive IL-17A production from other γδ T cell subsets [30–35]. Vγ4Vδ1 (Garman nomenclature [36]) T cells have traditionally been considered an innate-like cell. However, our group recently characterized a long-lived CD27- CD44hi Vγ4Vδ1 T cell memory
population in the context of foodborne Listeria monocytogenes infection [37,38]. While Vγ4 T
cells are typically programmed for IL-17A production, this subset has the multifunctional
capacity to produce both IL-17A and IFNγ [37]. Similar observations of IFNγ production were
made in clonally expanded Vγ4 T cells in response to Staphylococcus aureus in the skin [39].
IFNγ activates macrophages to kill intracellular pathogens or phagocytosed bacteria and
induces chemokines that attract immune cells to the site of infection. IFNγ is a critical cytokine
in protection from Y. enterocolitica infection [2,40], Y. pestis intranasal challenge [41], and
associated with protection from Y. pseudotuberculosis [42]. Interestingly, IFNγ but not IL-17A
production from type-3 innate lymphoid cells is critical for the control of foodborne Y. enterocolitica infection [43]. As such, unconventional T cells like Vγ4 T cells that are ideally placed to
provide protection against pathogen invasion at mucosal sites may be particularly relevant to
Yersinia infections that invade mucosal barriers of the lungs (pneumonic Y. pestis) and gut (Y.
pseudotuberculosis and Y. enterocolitica).
Despite a foundational understanding of Yersinia pathogenesis, physiologically robust evidence linking Yersinia pathogenesis to direct subversion of T cell function is lacking. Here, we
uncovered a novel YopJ-dependent immunomodulatory pathway used by Y. pseudotuberculosis to directly subvert a murine Vγ4Vδ1 anti-microbial response to aid Y. pseudotuberculosis
pathogenesis. Y. pseudotuberculosis also directly subverted a human Vδ2+ T cell IFNγ
response, suggesting that this pathway may function similarly in human infection to aid Y.
pseudotuberculosis pathogenesis.

Results
Viable Y. pseudotuberculosis inhibits IFNγ production by adaptive γδ T
cells in a YopB- and YadA-dependent manner
Initial experiments were carried out to determine if Y. pseudotuberculosis inhibits adaptive γδ
T cell function ex vivo. To overcome the extremely low number of Vγ4 T cells in gut-associated
lymphoid tissues of naïve specific pathogen free (SPF) mice, a previously established in vivo
methodology was utilized to generate a sizable population of adaptive Vγ4 T cells for in vitro
manipulation. As such, naïve Balb/c mice were exposed to foodborne L. monocytogenes and
MLN enriched in adaptive γδ T cells were isolated 9 days after infection [37], several days after
mice typically clear L. monocytogenes [44]. MLN single cell suspensions were infected directly
ex vivo with heat-killed or live wild-type (WT) Y. pseudotuberculosis (Yptb) 32777 (Table 1) at
a multiplicity of infection (MOI) of 10 for 2 hours. Antibiotics were then added to prevent
overgrowth of the live bacteria, and the cultures were incubated an additional 22 hours. Flow
cytometry in conjunction with intracellular cytokine staining was used to assess IFNγ production from Vγ1.1/2- CD44hi CD27- γδ T cells (identifying the adaptive Vγ4 T cell subset
[37,38]). Heat-killed Y. pseudotuberculosis elicited a significantly higher IFNγ response from
adaptive Vγ4 T cells than was detectable after stimulation with live Y. pseudotuberculosis (Fig
1A). This observation suggests that live Y. pseudotuberculosis subverts adaptive Vγ4 T cell
function. The virulence activity of Y. pseudotuberculosis relies substantially on its T3SS and
translocation of Yop effectors into host cells. To determine if the T3SS is required for live Y.
pseudotuberculosis inhibition of γδ T cell function, MLN single cell suspensions were infected
with WT Y. pseudotuberculosis or Y. pseudotuberculosis that were unable to translocate Yop
effectors (ΔYopB) or lacked the virulence plasmid that encodes the T3SS (32777c) (Table 1)
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Table 1. Y. pseudotuberculosis strains and mutants used in this study.
Y. pseudotuberculosis

Notation

Relevant Characteristics

References

32777

WT

Yptb wild-type serogroup O:1 strain

[47]

32777c

WT2777c

Virulence pYV-cured derivative of 32777 that lacks the T3SS

[47]

32777 YopJC172A

YopJC172A

Catalytically inactive YopJ

[45]

32777 YopHR409A

YopHR409A

Catalytically inactive YopH

[45,48,49]

32777 ΔYopB

ΔYopB

Deletion of YopB

32777 YopER144A

YopER144A

Catalytically inactive YopE

[45]

32777 YopTC139A

YopTC139A

Catalytically inactive YopT

[45]

32777 ΔYopM

ΔYopM

Deletion of YopM

[50]

32777 ΔYpkA

ΔYpkA

Deletion of YpkA

[51]

32777 ΔYopK

ΔYopK

Frameshift mutation in YopK

32777 YopE/β-lac

WT Yptb-βla

YopE TME-1 β-lactamase fusion protein

[53–55]

32777 ΔYopB YopE/β-lac

ΔYopB Yptb-βla

Deletion of YopB in the YopE/β-lac

[53–55]

IP2666

WT

Yptb wild-type serogroup O:3 strain

[47]

IP40

ΔYopB

IP2666 yopB40 (a stop codon at codon 8 of YopB followed by a frameshift)

IP2666 ΔInv

ΔInv

Deletion of adhesin and invasin

[12,57]

IP2666 ΔYadA

ΔYadA

Deletion of adhesin and YadA

[12,57]

IP2666 ΔInv ΔYadA

ΔInv ΔYadA

Deletion of adhesin, invasion, and YadA

[12,57]

IP40 ΔInv ΔYadA

ΔYopB ΔInv ΔYadA

Deletion of invasion and YadA in IP40 and pMMB207 mCherry

[12,57]

[45,46]

[52]

[56]

https://doi.org/10.1371/journal.ppat.1010103.t001

[45–47]. γδ T cell function was assessed 24 hours later as described above. Stimulation with
live Y. pseudotuberculosis strains ΔYopB or 32777c restored the IFNγ response of Vγ1.1/2CD44hi CD27- γδ T cells (Fig 1B), similar to levels seen after stimulation with heat-killed WT
Y. pseudotuberculosis (Fig 1A). These data indicate that Y. pseudotuberculosis inhibits IFNγ
production by Vγ4 T cells in a manner that requires the T3SS and translocation of Yop
effectors.
Y. pseudotuberculosis adheres to host cells with the bacterial adhesins invasin (Inv) and
YadA to translocate effectors through the T3SS [58–60]. For Y. enterocolitica, both Inv and
YadA bind β1-integrin either directly or indirectly through the extracellular matrix, respectively [61]. Additionally, β1-integrin expressed on host cells is a known adhesion target for Y.
pseudotuberculosis [60,62]. To evaluate the role of these adhesins in the inhibition of γδ T cell
function, live Y. pseudotuberculosis with a deletion of Inv (ΔInv), YadA (ΔYadA), or both
(ΔInv ΔYadA) (Table 1) were utilized to infect MLN cell suspensions. Vγ1.1/2- CD44hi CD27γδ T cells stimulated with ΔInv bacteria produced only minimal IFNγ, comparable to unstimulated cells or cells stimulated with WT (Fig 1C). In contrast, ΔYadA or ΔInv ΔYadA stimulation led to partial restoration of IFNγ production, and stimulation with ΔYopB or ΔYopB ΔInv
ΔYadA bacteria led to full restoration of IFNγ production (Fig 1C). Thus, YadA but not Inv
contributes to translocation dependent inhibition of IFNγ production by Vγ4 T cells.

Translocation of Yop effectors into adaptive γδ T cells by Y.
pseudotuberculosis is associated with IFNγ inhibition
To determine if Y. pseudotuberculosis can translocate Yop effectors into adaptive Vγ4 T cells, a
WT strain expressing a YopE-β-lactamase fusion protein (Yptb-βla) in conjunction with a
FRET-based β-lactamase reporter assay was used [63]. YopE translocation into target cells can
be readily assessed by a change in fluorescence using flow cytometry. Thus, translocation of
the YopE-β-lactamase fusion protein reports Yop effector translocation by emission in the
blue range (Yop+) or lack thereof by emission in the green range (Yop-) [10,64,65]. A YopB
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Fig 1. Y. pseudotuberculosis inhibition of Vγ1.1/2- CD44hi CD27- γδ T cell function is YopB- and YadAdependent. MLN cell suspensions from L. monocytogenes infected Balb/c mice were left unstimulated or stimulated
with 10 MOI of the indicated Y. pseudotuberculosis for 24 hours. Antibiotics were given 2 hours post-stimulation and
brefeldin A was added for the last 5 hours of stimulation. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for IFNγ
production. Representative histograms are displayed. (A) Cells were stimulated with live or heat-killed (HK) wild-type
(WT) Y. pseudotuberculosis. The graph depicts the mean ± SEM and represents at least two independent experiments
with 4 mice/group/experiment. (B) Cells were stimulated with live WT, ΔYopB, or 32777c Y. pseudotuberculosis. The
graph depicts the mean ± SEM and represents at least two independent experiments with 4 mice/group/experiment.
(C) Cells were stimulated with WT, ΔYopB, ΔYadA, ΔInv, ΔInv ΔYadA, or ΔYopB ΔInv ΔYadA Y. pseudotuberculosis.
The graph depicts the mean ± SEM pooled from two independent experiments with 3 mice/group/experiment.
���
p < 0.0001, �� p < 0.01, and � p < 0.05. An unpaired t-test was used for (A) and a repeated measures one-way
ANOVA was used for (B) and (C). Experimental groups were compared to live WT Y. pseudotuberculosis in (A) and
WT Y. pseudotuberculosis in (B) and (C).
https://doi.org/10.1371/journal.ppat.1010103.g001

deficient β-lactamase Y. pseudotuberculosis reporter (ΔYopB Yptb-βla) was used as a translocation deficient control. Stimulation of MLN cell suspensions with WT or ΔYopB Yptb-βla confirmed reporter activity at various MOI (S1A and S1B Fig). Two hours post stimulation with
WT Yptb-βla, the majority of Vγ1.1/2- CD44hi CD27- γδ T cells were positive for Yop effector
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translocation (Fig 2A). Yop translocation into Vγ1.1/2- CD44hi CD27- γδ T cells was comparable to known DC and macrophage targets (Fig 2A). Additionally, Yop translocation was more
efficient into Vγ1.1/2- CD44hi CD27- γδ T cells than CD4 or CD8 T cells (Fig 2A). Y. pseudotuberculosis also preferentially targeted Vγ1.1/2- CD44hi CD27- γδ T cells over CD44- γδ T cells
and activated phenotype CD4 or CD8 T cells for Yop translocation (S1C Fig). YadA and Inv
promote Yersinia adherence by direct or indirect interactions with the β1-integrin [66–69].
Analysis of β1-integrin expression on Vγ1.1/2- CD44hi CD27- γδ T cells, CD4 T cells, and CD8
T cell revealed that most Vγ1.1/2- CD44hi CD27- γδ T cells expressed the β1-integrin (S2A
Fig). In contrast, most conventional CD4 and CD8 T cells did not express the β1-integrin. In
addition, use of the WT Yptb-βla reporter for Yop translocation demonstrated that Yop translocation was associated with higher β1-integrin expression among γδ T cells (S2B Fig). Thus,
Y. pseudotuberculosis selectively targets adaptive γδ T cells for Yop translocation among a
diverse group of immune populations assessed in an ex vivo culture system.
As adaptive Vγ4 T cells were directly targeted with Yop effector translocation, WT Yptb-βla
was utilized to determine whether Vγ1.1/2- CD44hi CD27- γδ T cells that contained Yop effectors were functionally impaired. An MOI of 1 was used as it provided similarly sized populations of Vγ1.1/2- CD44hi CD27- γδ T cells that did or did not contain translocated effectors
from the same culture conditions (S1B Fig). Among WT Yptb-βla stimulated cells, Yop+
Vγ1.1/2- CD44hi CD27- γδ T cells had reduced IFNγ production as compared to their Yopcounterparts (Fig 2B). To extend these results, the ability of Y. pseudotuberculosis to translocate
Yop effectors into human γδ T cells and inhibit IFNγ production was assessed in peripheral
blood mononuclear cells (PBMC) cultures stimulated with the WT Yptb-βla reporter. Approximately 8% of human Vδ2+ T cells were Yop+ and these cells had significantly reduced IFNγ
production as compared to the Yop- counterparts (Fig 2C and 2D). These data indicate that Y.
pseudotuberculosis is capable of translocating Yop effectors into γδ T cell subsets and inhibiting
IFNγ production in mice and humans.

YopJ is necessary for Y. pseudotuberculosis to inhibit IFNγ production in
adaptive γδ T cells
As multiple effectors are translocated into target cells, a panel of yop mutant Y. pseudotuberculosis (Table 1) [45] was screened to determine if individual Yop effectors inhibit IFNγ production. Similar to the ΔYopB mutant, stimulation with a catalytically inactive YopJ (YopJC172A)
mutant that lacks acetyl transferase activity, but not other mutant Y. pseudotuberculosis,
restored IFNγ production in Vγ1.1/2- CD44hi CD27- γδ T cells (Fig 3A). The C172A mutation
in YopJ prevents YopJ mediated inhibition of MAPK and NF-κB signaling pathways by abolishing its serine and threonine acetylation activity [70]. A similar restoration of IFNγ production was observed in human Vδ2+ T cells from PBMC of healthy donors upon YopJC172A Y.
pseudotuberculosis stimulation (Fig 3B). Thus, the YopJ effector is responsible for inhibition of
IFNγ production from murine Vγ4 and human Vδ2+ T cells.

YopJ inhibits expression of multiple genes, including ifng, in adaptive γδ T
cells
To uncover mechanisms by which YopJ inhibits IFNγ production, the transcriptome of cell
sorter-purified Vγ1.1/2- CD44hi CD27- γδ T cells after WT or YopJC172A Y. pseudotuberculosis
stimulation of MLN cells was assessed by RNA-Seq. Principal component analysis revealed
unique gene expression clustering, and approximately 900 genes were expressed at higher levels in the YopJC172A stimulation as compared to WT Y. pseudotuberculosis (Fig 4A and 4B).
These differentially expressed genes may include genes that are directly inhibited by YopJ
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Fig 2. Direct translocation of Yop effectors inhibits the function of murine Vγ4 and human Vδ2+ T cells. MLN suspensions from L.
monocytogenes infected mice (A and B) or human PBMC (C and D) were left unstimulated or stimulated with WT or ΔYopB Yptb-βla as
indicated. Cells were loaded with CCF4-AM dye prior to stimulation to measure β-lactamase activity. FITC indicates CCF4-AM loaded cells
without translocation (Yop-) and BV421 indicates CCF4-AM loaded cells with Yop translocation (Yop+). (A) Adaptive γδ T cells (Vγ1.1/2CD44hi CD27- γδ T cells), DC (CD11chi MHCIIhi), Macrophages (F4/80+ CD11b+), and CD4 and CD8 T cells were analyzed for Yop
translocation 2 hours post stimulation at an MOI of 10. Representative contour plots are displayed. Yop translocation among the indicated
populations is depicted as mean ± SEM and is pooled from 2 experiments with a total of 4–8 mice per group. (B) Antibiotics were given 2
hours post-stimulation and brefeldin A was added for the last 5–6 hours of stimulation. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for
Yop translocation and IFNγ production 24 hours after stimulation. Representative contour plots and histograms are shown. IFNγ production
among the indicated populations is depicted as mean ± SEM and is pooled from 3 experiments with a total of 8 mice per group. (C and D)
Antibiotics were given 2 hours post-stimulation and brefeldin A was added for the last 5–6 hours of stimulation. Vδ2+ T cells were analyzed for
Yop translocation and IFNγ production post stimulation. Representative contour plots are displayed and IFNγ production is quantified among
Yop+ or Yop- Vδ2+ T cells. The graph depicts mean ± SEM and is pooled from 3 experiments with 5 healthy donors per group. ���� p < 0.0001,
���
p < 0.001, �� p < 0.01, and � p < 0.05. An ordinary one-way ANOVA was used for (A), a repeated measures one-way ANOVA was used for
(B), and a paired t-test was used for (D). Comparisons were performed to adaptive γδ T cells in (A), to unstimulated or as depicted in figure in
(B), and to Yop+ in (C).
https://doi.org/10.1371/journal.ppat.1010103.g002

activity in Vγ1.1/2- CD44hi CD27- γδ T cells or indirectly inhibited by YopJ activity in other
cells such as DC or macrophages. To resolve this, the WT Yptb-βla reporter provided an
opportunity to evaluate the molecular changes elicited by the activity of translocated Yop in
adaptive γδ T cells. The transcriptome of sort purified Yop- and Yop+ Vγ1.1/2- CD44hi CD27γδ T cells after WT Yptb-βla stimulation was assessed by RNA-Seq. Principal component analysis revealed unique gene expression clustering, and approximately 900 genes were more
highly expressed in Yop- vs Yop+ Vγ1.1/2- CD44hi CD27- γδ T cells after WT Yptb-βla stimulation (Fig 4C and 4D). Overlapping gene expression profiles from the two datasets were
assessed to narrow the analysis to direct YopJ effects on Vγ1.1/2- CD44hi CD27- γδ T cells.
This comparison revealed 130 genes that were differentially expressed in both datasets, suggesting they are regulated directly by translocated YopJ in adaptive Vγ4 T cells (Fig 4E). These
genes were categorized into different groups depending on their known functions. Some differentially expressed genes play a particular role in anti-infection functions (3.9%), stress sensing (1.6%), and lymphocyte activation/regulation (7.9%), genes that may be important for
protective T cell responses (Fig 4E and 4F). Among these genes, IFNγ was the single most significant differentially expressed gene suggesting it is a major target of direct YopJ-mediated
inhibition of adaptive γδ T cell function (Fig 4F). Differentially expressed genes among those
that promote antimicrobial function included several that are important in augmenting type-1
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Fig 3. YopJ is necessary for inhibition of IFNγ production in murine Vγ4 and human Vδ2+ T cells. (A) MLN from L. monocytogenes infected
mice were left unstimulated or stimulated with 10 MOI of the indicated Y. pseudotuberculosis for 24 hours. Antibiotics were given 2 hours poststimulation and brefeldin A was added for the last 5–6 hours. Vγ1/2- CD44hi CD27- γδ T cells were analyzed for IFNγ post stimulation.
Representative histograms are displayed. The graph depicts mean ± SEM and represents at least two independent experiments with 2–4 mice per
group. (B) Human PBMC were stimulated with 1 MOI of WT or YopJC172A Y. pseudotuberculosis for 24 hours. Antibiotics were given 2 hours poststimulation. Brefeldin A was added for the last 5–6 hours of stimulation. Vδ2+ γδ T cells were analyzed for IFNγ production post stimulation.
Representative flow plots gated on Vδ2+ T cells are displayed. The graph depicts mean ± SEM and is pooled from 2 experiments with 4 healthy
donors. �� p < 0.01 and � p < 0.05. A repeated measures one-way ANOVA was used for (A) and a paired t-test was used for (B). Experimental groups
were compared to WT Y. pseudotuberculosis.
https://doi.org/10.1371/journal.ppat.1010103.g003

and -3 inflammation in T cells. For example, Ptgs2 (encodes cyclooxygenase-2, COX2), Nkg7
(natural killer cell granule protein 7), Prf1 (perforin-1), and Il17a (IL-17A) appear to be regulated directly by translocated YopJ in adaptive Vγ4 T cells (Fig 4F) [71–73]. However, analysis
of IL-17A protein after stimulation of MLN cell suspensions with YopJC172A, WT, and ΔYopB
Y. pseudotuberculosis demonstrated that YopJ did not regulate IL-17A production from Vγ1.1/
2- CD44hi CD27- γδ T cells (S4 Fig). Some of the observed differentially expressed genes are
important in the activation status of T cells (e.g., Il2ra, Ctla4, and Cd69) and suggest that translocated YopJ may limit the activation of adaptive Vγ4 T cells. There was also a notable impact
(48.0%) on genes associated with cell proliferation, metabolism and energy, mitosis and cell
cycle, RNA/DNA processing, and ER/Golgi processing (Figs S3A and S3B and 4E), suggesting
that YopJ influences the adaptive γδ T cell transcriptional profile more broadly than just targeting the IFNγ pathway. Genes that were differentially expressed upon WT Y. pseudotuberculosis stimulation or among Yop+ cells also suggest that many of the processes associated with
immune responses and cellular activity were regulated by YopJ (S3C–S3E Fig). Collectively,
YopJ appears to regulate the expression of many genes associated with T cell function in
Vγ1.1/2- CD44hi CD27- γδ T cells, suggesting that adaptive Vγ4 T cells are broadly constrained
in their immune functions by Y. pseudotuberculosis.

YopJ inhibits the IL-12p40-mediated STAT4 pathway in adaptive γδ T cells
To gain potential mechanistic insights into YopJ inhibition of IFNγ production and other
Vγ1.1/2- CD44hi CD27- γδ T cell functions, a motif discovery algorithm designed for regulatory element analysis was utilized to assess our RNA sequencing results [74]. Several transcription factor binding motifs related to IFNγ signaling were differentially expressed after
YopJC172A Y. pseudotuberculosis but not WT Y. pseudotuberculosis stimulation including members of the E twenty-six (ETS)-domain family, Krüppel-like factor and specificity protein
(KLF/SP) transcription factor gene family, and the interferon regulatory factors (IRF) family
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Fig 4. YopJ translocation leads to the inhibition of a broad anti-microbial gene response from Vγ4 T cells. (A and B) MLN suspensions from L.
monocytogenes infected mice were stimulated with 10 MOI of WT or YopJC172A Y. pseudotuberculosis for 24 hours. Antibiotics were given 2 hours poststimulation. Five hundred Vγ1.1/2- CD44hi CD27- γδ T cells from each stimulation were flow sorted and processed for RNA sequencing. (A) PCA plots
are depicted for similarity of groups YopJC172A and WT Y. pseudotuberculosis stimulated Vγ1.1/2- CD44hi CD27- γδ T cells. (B) Heat maps are depicted
for differentially expressed genes of YopJC172A or WT Y. pseudotuberculosis stimulated Vγ1.1/2- CD44hi CD27- γδ T cells. (C and D) MLN suspension
from L. monocytogenes infected mice were stimulated with 1 MOI of WT Yptb-βla. Five hundred Yop+ or Yop- Vγ1.1/2- CD44hi CD27- γδ T cells were
flow sorted and processed for RNA sequencing. (C) PCA plots are depicted for similarity of Yop+ or Yop- Vγ1.1/2- CD44hi CD27- γδ T cells. (D) Heat
maps are depicted for differentially expressed genes of Yop- or Yop+ stimulated Vγ1.1/2- CD44hi CD27- γδ T cells. (E-G) A Venn diagram of
differentially expressed genes (higher) that overlapped between RNA sequencing analyses favoring YopJC172A Y. pseudotuberculosis stimulation or Yopcells is displayed. Shared genes were categorized by gene function. (F) The heat map highlights differentially expressed genes among Vγ1.1/2- CD44hi
CD27- γδ T cells from the indicated stimulations and categories. (G) Homer motif analysis was performed on the RNA sequencing dataset. Motifs and
associated genes to YopJC172A stimulated Vγ1.1/2- CD44hi CD27- γδ T cells are highlighted. Each experiment was performed with 3 biologic samples per
group. Cutoffs for significant genes are p < 0.05 and FDR < 0.10.
https://doi.org/10.1371/journal.ppat.1010103.g004

of transcription factors (S5A Fig). IRF8 protein was validated after WT, ΔYopB, and YopJC172A
Y. pseudotuberculosis stimulation. Indeed, a higher percentage of Vγ4 T cells expressed IRF8
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protein after stimulation with ΔYopB compared to WT Y. pseudotuberculosis stimulation (S5B
Fig). Stimulation with YopJC172A Y. pseudotuberculosis was also able to partially restore IRF8
levels to those seen after ΔYopB Y. pseudotuberculosis stimulation (S5B Fig). IRF8 was also
impacted by IL-12p40 blockade, which signals through signal transducer and activator of transcription 4 (STAT4) (S5B Fig). Interestingly, a number of transcription factor binding motifs
downstream of STAT4 signaling were enriched including Etv5, Runx3, and Tead1 (Fig 4G)
[75–78]. The RNAseq and homer motif analyses were also compared to an existing STAT4
ChIP-on-chip [79]. 7 genes identified from our main analyses (Figs 4F and 4G and S5B) were
STAT4 target genes (S5C Fig). In summary, transcriptional profiling revealed a global subversion of anti-pathogen immune functions that may be associated with YopJ subversion of
STAT4 activity.
IL-12 signaling leads to STAT4 phosphorylation and formation of STAT4-STAT4 homodimers that re-localize to the nucleus where they directly bind to the Ifng promoter to induce
IFNγ expression [79–81]. To determine whether YopJ inhibits IFNγ production by interfering
with the STAT4 pathway, STAT4 protein and phosphorylation were assessed by flow cytometry of MLN cells stimulated with Y. pseudotuberculosis. STAT4 phosphorylation was analyzed
6 hours after stimulation with WT, ΔYopB, or YopJC172A Y. pseudotuberculosis. Consistent
with suppression of IFNγ production and the RNA-Seq analysis, WT Y. pseudotuberculosis significantly reduced the percentage of pSTAT4+ CD44hi CD27- γδ T cells as compared to ΔYopB
and YopJC172A Y. pseudotuberculosis (Fig 5A). However, STAT4 protein levels were the same
in all three infection conditions (WT, ΔYopB, and YopJC172A Y. pseudotuberculosis) (Fig 5B).
Flow cytometry antibodies for STAT4 protein were validated by comparing STAT4 from WT
and STAT4 KO splenocytes (S5D Fig). These data suggest that STAT4 phosphorylation but
not protein is decreased upon YopJ translocation. STAT4 phosphorylation was also evaluated
using the Yptb-βla reporter system described above. Among CD44hi CD27- γδ T cells, Yopcells had a higher percentage of pSTAT4+ cells compared to Yop+ cells suggesting intrinsic
Yop mediated inhibition of STAT4 phosphorylation levels (Fig 5C). Additionally, as STAT4
phosphorylation is downstream of IL-12 signaling, an anti-IL-12/23p40 subunit antibody
(anti-p40) was used to determine whether IL-12 signals in the environment regulated STAT4
phosphorylation after Y. pseudotuberculosis stimulation. Indeed, IL-12/23p40 neutralization
abrogated STAT4 phosphorylation levels regardless of Yop translocation (Fig 5C). As IL-12/
23p40 was required to elicit IFNγ production from adaptive Vγ4 T cells in the culture conditions, we assessed whether YopJC172A Y. pseudotuberculosis stimulation modulated IL-12p70.
The concentration of IL-12p70 was comparable between WT and YopJC172A Y. pseudotuberculosis stimulated cultures (Fig 5D). Thus, changes in IL-12 were unlikely to contribute to adaptive Vγ4 T cell subversion in vitro. To understand the role of YopJ and IL-12 on Vγ1.1/2CD44hi CD27- γδ T cells in a more simplified system, purified γδ T cells were stimulated with
YopJC172A Y. pseudotuberculosis in the presence of excessive IL-12p70. Adaptive Vγ4 T cells
were unable to produce IFNγ in response to YopJC172A Y. pseudotuberculosis and IL-12p70
(S6A Fig). Finally, we assessed whether the addition of IL-12p70 could overcome the YopJ
mediated inhibition of IFNγ production after WT Y. pseudotuberculosis stimulation. While a
supraphysiologic level of IL-12p70 (50 ng/ml) was able to partially overcome YopJ mediated
inhibition, lower levels of IL-12p70 addition (2 and 10 ng/ml) were unable to overcome YopJ
mediated inhibition (S6B Fig). Importantly, these latter concentrations were orders of magnitude higher than those detected in our culture conditions. Thus, IL-12 is not sufficient to
induce IFNγ production from adaptive Vγ4 T cells. Collectively, these results suggest that Y.
pseudotuberculosis stimulation elicits IL-12 production to promote adaptive Vγ4 T cell IFNγ
responses, and that YopJ translocation into adaptive Vγ4 T cells inhibits IL-12 mediated
STAT4 phosphorylation.
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Fig 5. YopJ inhibits IL-12p40 mediated STAT4 phosphorylation. (A) MLN cell suspensions from L. monocytogenes infected mice were stimulated
with 10 MOI of WT, YopJC172A, or ΔYopB Y. pseudotuberculosis for 6 hours. Antibiotics were given 2 hours after stimulation. Vγ1.1/2- CD44hi CD27γδ T cells were analyzed for pSTAT4 after stimulation. Representative contour plots are displayed. The graph depicts mean ± SEM and represents at
least two independent experiments with 2–4 mice per group. (B) The same experimental setup was used as in (A), but Vγ1.1/2- CD44hi CD27- γδ T
cells were analyzed for STAT4 protein after stimulation. Representative plots for mean fluorescent intensity (MFI) are displayed. The graph depicts
mean ± SEM and represents two independent experiments with 2 mice per group. (C) MLN suspensions from L. monocytogenes infected mice were
either treated or untreated with IL-12/23p40 neutralizing antibody prior to stimulation with 1 MOI of WT Yptb-βla for 6 hours. Antibiotics were
given 2 hours post-stimulation. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for pSTAT4 after stimulation. Representative contour plots are
displayed. The graph depicts mean ± SEM and represents at least two independent experiments with 2–4 mice per group. (D) MLN cell suspensions
from L. monocytogenes infected mice were stimulated with 10 MOI of WT or YopJC172A Y. pseudotuberculosis for 24 hours. Antibiotics were given 2
hours after stimulation. Supernatants were collected 24 hours post stimulation and IL-12p70 concentration was determined via ELISA.
����
p < 0.0001, ��� p < 0.001, �� p < 0.01, and � p < 0.05. A repeated measures one-way ANOVA was used for (A-C). Comparisons were performed to
WT Y. pseudotuberculosis in (A) and as depicted in (B-D).
https://doi.org/10.1371/journal.ppat.1010103.g005

Foodborne infection with YopJC172A Y. pseudotuberculosis induces IFNγ
production in adaptive Vγ4 T cells
To determine whether YopJ subverts adaptive γδ T cell function in vivo, foodborne infection
with WT and YopJC172A Y. pseudotuberculosis was performed on naïve Balb/c mice. As
YopJC172A Y. pseudotuberculosis is attenuated in vivo [82], a one log higher (2-4x108 CFU)
infection dose of YopJC172A Y. pseudotuberculosis was administered to normalize the internal
bacteria burdens in the MLN between infection groups (S7A Fig). While mice infected with
WT and YopJC172A Y. pseudotuberculosis lost a similar amount of weight, mice infected with
YopJC172A Y. pseudotuberculosis recovered slightly faster (Fig 6A). MLN were isolated 9 days
after infection to evaluate adaptive γδ T cell function. Consistent with the ex vivo stimulation
of L. monocytogenes-elicited Vγ4 T cells with Y. pseudotuberculosis, Vγ1.1/2- CD44hi CD27- γδ
T cells from the MLN of YopJC172A Y. pseudotuberculosis infected mice displayed enhanced
IFNγ production when stimulated ex vivo compared to their WT Y. pseudotuberculosis
infected counterparts (Fig 6B and 6C). When the same infectious doses were used for both
WT and YopJC172A Y. pseudotuberculosis (5x107 CFU), Vγ1.1/2- CD44hi CD27- γδ T cells from
the MLN of YopJC172A Y. pseudotuberculosis infected mice also displayed enhanced IFNγ
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Fig 6. Foodborne YopJC172A Y. pseudotuberculosis infection elicits an IFNγ response from Vγ4 T cells. (A-E) Balb/c mice were
foodborne infected with WT (2-4x107 CFU) or YopJC172A Y. pseudotuberculosis (2-4x108 CFU). (A) Mouse weight was assessed
daily after infection. (B and C) Nine days post infection, MLN were processed into single cell suspensions and stimulated with
PMA/ionomycin in the presence of brefeldin A for 4 hours. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for IFNγ production.
Representative histograms are displayed. Graphs represent mean ± SEM and are pooled from 3 experiments with a total of 5–8 mice
per group. (D) Mouse survival was assessed daily after infection. anti-IL-12p40 antibody was administered at 0.2 mg/mouse on 0, 2,
4, and 6 days post infection. A Kaplan-Meier survival plot is shown. Study endpoint was 9 days post infection. The data represent 2
independent experiments with a total of 9 mice per group. (E and F) Balb/c mice were foodborne infected with 2x109 CFU L.
monocytogenes to elicit a Vγ1.1/2- CD44hi CD27- γδ T cell population in vivo. 30 days post infection, immunized mice were
foodborne infected with WT Yptb-βla (2-4x109 CFU) or left uninfected. (E) CFU of WT Yptb-βla were enumerated in MLN 3 days
post WT Yptb-βla infection. (F) Three days post foodborne WT Yptb-βla infection, Vγ1.1/2- CD44hi CD27- γδ T cells from the
MLN were analyzed for Yop translocation using the CCF4-AM assay. Representative contour plots are shown. Yop translocation
(Yop+) among the indicated populations is depicted as mean ± SEM and is pooled from 2 experiments with a total of 4 mice per
group. ��� p < 0.001, �� p < 0.01, and � p < 0.05. A repeated measures one-way ANOVA was used for (A and F) and an unpaired ttest was used for (B, C, and E). Experimental groups were compared to WT Y. pseudotuberculosis in (A-C), uninfected controls in
(E), and Vγ1.1/2- CD44hi CD27- γδ T cells in (F). A logrank test was used for survival curves in (D).
https://doi.org/10.1371/journal.ppat.1010103.g006

production compared to their WT Y. pseudotuberculosis infected counterparts (S7B Fig).
These experiments demonstrate that the increased IFNγ observed was not a result of a higher
infectious dose nor of a higher bacteria burden at the time of analysis. As IL-12/23p40 was
required for adaptive Vγ4 T cell IFNγ production in vitro (Fig 5), the impact of IL-12/23p40
was assessed in vivo. Naïve Balb/c mice were infected with WT or YopJC172A Y. pseudotuberculosis and treated with an IL-12/23p40 neutralizing antibody or isotype control. All YopJC172A
Y. pseudotuberculosis infected mice treated with anti-IL-12/23p40 succumbed by day 8 post
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infection (Fig 6D). This data suggests that IL-12 promotes the protective capacity of catalytically inactive YopJ. Similarly, IL-12 contributed to the protection of mice infected with WT Y.
pseudotuberculosis. Serum was also collected on days 2, 4 and 6 after infection to assess circulating IL-12p70 levels. IL-12p70 was detectable 6 days after YopJC172A Y. pseudotuberculosis
infection but was mostly below the limit of detection after WT Y. pseudotuberculosis infection
(Fig 6E). Collectively, these data suggest that IL-12 is important in the protection of mice
infected with WT or YopJC172A Y. pseudotuberculosis.
Foodborne infection with WT Yptb-βla was performed to determine whether Y. pseudotuberculosis could target adaptive Vγ4 T cells with Yop translocation in vivo. Balb/c mice were
foodborne infected with L. monocytogenes to elicit a population of Vγ1.1/2- CD44hi CD27- γδ
T cells as described previously [37,83]. After a return to homeostasis at 30 days post L. monocytogenes infection, mice were foodborne infected with WT Yptb-βla. Y. pseudotuberculosis burden was assessed in the MLN 3 days post foodborne infection to determine whether WT Yptbβla could establish a productive infection where Vγ4 T cells reside. Indeed, infected mice contained detectable Y. pseudotuberculosis in the MLN 3 days after foodborne infection (Fig 6F).
Analysis of the translocation of Yop into Vγ1.1/2- CD44hi CD27- γδ T cells, myeloid cells
(CD11b+), and CD4 and CD8 T cells was performed. Consistent with our in vitro observations,
Vγ1.1/2- CD44hi CD27- γδ T cells and myeloid cells contained translocated Yop in vivo (Fig
6G). Y. pseudotuberculosis was relatively inefficient at Yop translocation into CD4 and CD8 T
cells (Figs 6G and S7C). Collectively, these data show that foodborne YopJC172A Y. pseudotuberculosis infection of naïve mice elicits IFNγ production in adaptive γδ T cells and that Yop
can be translocated into adaptive Vγ4 T cells in vivo.

Discussion
In this study, we assessed the subversion of an adaptive subset of γδ T cells specialized in the
promotion of pathogen resistance at the intestinal mucosa through the production of antiinfective cytokines like IFNγ and IL-17A [37]. While limited evidence suggests that Yop effectors directly target T cells to subvert their function, we identified that the Y. pseudotuberculosis
effector molecule YopJ directly inhibits IFNγ production from adaptive CD44hi CD27- γδ T
cells to subvert host immunity in mice. Additionally, we demonstrate that circulating human
Vδ2+ T cells are similarly inhibited by direct translocation of YopJ, demonstrating that the
direct targeting of γδ T cells by Y. pseudotuberculosis to inhibit IFNγ production is a conserved
pathway of immune evasion in humans. Thus, Y. pseudotuberculosis Yop effectors translocated
into murine Vγ4 T cells and human Vδ2+ T cells directly subvert their anti-microbial functions
and host immunity by limiting IFNγ production.
While Yersinia mediated inhibition of conventional T cells has been previously reported,
studies have largely focused on the indirect subversion of T cells that is mediated by translocation of Yop effectors into myeloid cells [55,82]. For example, YopJ/P appears to primarily subvert conventional T cell function through indirect mechanisms associated with inhibiting DC
[22,26]. On the contrary, the study of γδ T cells in the context of Y. pseudotuberculosis infection
has been primarily limited to the potential antigens that drive γδ T cell recognition of infection
[84–89].
After phagocytosis of pathogens, activated DC migrate to lymph nodes and present antigen
to T cells. APC-derived IL-12 further shapes T cell responses by providing a critical signal during T cell activation [90]. Interestingly, Y. pestis can limit both the migratory capacity of DC
and the production of IL-12 [91], and Y. enterocolitica can induce programmed death of DC
and inhibit antigen presentation [22]. Y. pseudotuberculosis YopJ can also indirectly limit NK
cell function by interfering with DC TLR4 signaling pathways and YopP in Y. enterocolitica
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can limit NK cell function through STAT4 inhibition [21,92]. Given that IL-12 signaling promotes STAT4 phosphorylation and IFNγ production in γδ T cells [29,93] and Yersinia spp. can
inhibit DC, a potential extrinsic mechanism emerges for Y. pseudotuberculosis to inhibit γδ T
cell responses by suppressing DC functions. In line with these observations, IL-12p40 was critical for the induction of phospho-STAT4 in Vγ4 T cells after stimulation with Y. pseudotuberculosis in in vitro cultures. In contrast, Y. pseudotuberculosis and IL-12 were unable to directly
elicit IFNγ production from a highly enriched population of in vitro expanded γδ T cells suggesting that IL-12 is required but not sufficient for Vγ4 T cell IFNγ production. However,
stimulation of MLN cell suspensions with ΔYopB or YopJC127A Y. pseudotuberculosis elicited
STAT4 phosphorylation among Vγ4 T cells suggesting that translocation of Yop effectors and
YopJ in particular subverts Vγ4 T cell function. Tracking Yop translocation in vitro revealed
that Vγ4 T cells that contain Yop had reduced pSTAT4 levels and inhibited IFNγ production.
Importantly, Vγ4 T cells that did not contain Yop effectors from the same cultures expressed
higher pSTAT4 levels and comparable IFNγ production as Vγ4 T cells stimulated with
ΔYopB-βla Yptb. Additionally, IL-12 levels were comparable between cultures stimulated with
WT and YopJC172A Y. pseudotuberculosis. Collectively, these data suggest that functional
impairment of Vγ4 T cells was mediated by direct translocation of YopJ into Vγ4 T cells and
cell intrinsic mechanisms in vitro.
The YopJ effector family has been increasingly described by their acetyltransferase function
on serine, threonine, and lysine amino acid residues [19,94]. Serine and threonine are common targets of phosphorylation to propagate signaling cascades or elicit functional consequences. For example, phosphorylation of STAT4 leads to dimerization and transport to the
nucleus to promote transcription of STAT4 target genes. Acetylation of these target residues
may inhibit phosphorylation and downstream signaling events [70]. Thus, a potential mechanism of YopJ subversion of Vγ4 T cells is through acetylation of STAT4 to inhibit the phosphorylation or dimerization of STAT4. Other potential targets of YopJ acetyltransferase
activity are the IL-12R and Janus kinases upstream of STAT4 activation. YopJ has also been
reported to have cysteine protease, lysine acetyltransferase, ubiquitin-like protein protease,
and deubiquitinase activity that may provide other potential avenues for YopJ to modulate the
function of Vγ4 T cells through STAT4 [94–96].
An important aspect of Y. pseudotuberculosis pathogenesis unveiled by this work is the preferential targeting of a specialized subset of γδ T cells for delivery of inhibitory Yop effector
molecules. Y. pseudotuberculosis injected Yop effectors into adaptive γδ T cells in a similar proportion as macrophages and DC and to a much greater extent than conventional CD4 or CD8
T cells. Of note, Y. pseudotuberculosis has been reported to translocate Yop effectors more efficiently into Treg cells than conventional CD4 T cells at high MOI to modulate their function
[65]. The preferential targeting of Vγ4 T cells in this system is associated with expression of the
β1-integrin by adaptive Vγ4 T cells. Additionally, the majority of adaptive Vγ4 T cells are
anatomically segregated from conventional T cells in the paracortex by their localization in the
interfollicular and medullary areas of the gut draining lymph nodes [38]. The distinct localization of adaptive Vγ4 T cells may facilitate interactions with Y. pseudotuberculosis in vivo. Loss
of the adhesin YadA but not Inv abrogated YopJ mediated γδ T cell inhibition, suggesting that
Y. pseudotuberculosis utilizes YadA to target adaptive γδ T cells for Yop translocation, consistent with previous studies suggesting that the adhesin Inv is largely dispensable for Y. enterocolitica virulence [61,97]. Interestingly, this appears distinct from the targeting of conventional
CD4 T cells that relies on Inv and is enhanced in the absence of YadA [11,65].
While our data demonstrates that STAT4 phosphorylation is inhibited by YopJ, our RNASeq analysis suggests that other targets may also be affected. One of YopJ’s known targets is the
MAPK family of proteins that can have broad effects on cell proliferation, differentiation,
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survival, and apoptosis [18]. The MAPK pathway in CD4 T cells and NK cells may also promote STAT4 activity and downstream IFNγ mRNA stabilization, respectively [98,99]. Our
data demonstrate a broad impact of YopJ on adaptive γδ T cell proliferation, metabolism, cell
cycle, RNA/DNA processing, and ER/Golgi processing gene expression networks. These pathways may be regulated by MAPK family member activity [100–105]. Homer motif analysis
identified other potential means by which YopJ may regulate IFNγ production. For example,
Ets-1 is a T-bet cofactor and necessary for Th1 IFNγ responses [106]. Increases in ETS-domain
family of transcription factor motifs were associated with type 3 innate lymphoid cells (ILC3)
but not Th17 cells [107], which may suggest that one of the potential mechanisms of YopJ
mediated inhibition may target conserved pathways in unconventional lymphocyte populations. Many NK cell receptors are also expressed on γδ T cells and may facilitate TCR independent effector functions [108–110]. In line with this, our profiling demonstrates that YopJ
limits gene expression of Nkg7, which has recently been reported to promote cytotoxic granule
release and inflammation during infection and cancer [72], and Prf1, which encodes the pore
forming molecule perforin necessary to deliver lytic machinery into target cells [111]. Finally,
interactions with Y. pseudotuberculosis YopJ led to the upregulation of Ulbp1, which encodes a
stress-induced NKG2D ligand, and Idi1, which encodes an enzyme in the mevalonate pathway.
As human γδ T cells respond to phospho-antigens derived from the non-mevalonate pathway
in bacteria and mammalian mevalonate pathway in humans [112], this may limit the removal
of translocated cells through NK or γδ T cell sensing mechanisms and suggests a broad mechanism to subvert human immunity. Thus, our findings suggest that adaptive Vγ4 T cells provide
dynamic anti-infectious immunity that is subverted by direct translocation of YopJ.
A number of studies have highlighted the importance of IFNγ production from conventional CD4 and CD8 T cells, NK cells, and ILC3 for Yersinia resistance [40,43,113,114],
although the in vivo relevance of Yop inhibition of conventional T cells has not been
addressed. Foodborne infection with YopJC172A Y. pseudotuberculosis led to an enhanced
response from Vγ4 T cells, including increased IFNγ production, that was associated with a
more rapid recovery of weight. As IL-12 was critical for Vγ4 T cell derived IFNγ production in
vitro, the role of IL-12 after foodborne infection of Balb/c mice was assessed. Consistent with
previous studies [22,40,115,116], IL-12 appeared critical for protection against foodborne WT
and YopJC172A Y. pseudotuberculosis infection. As serum IL-12 was only readily detectable
after YopJC172A Y. pseudotuberculosis infection, increased IL-12 may also contribute to the
enhanced IFNγ response from Vγ4 T cells in vivo. Finally, assessment of cell populations targeted for Yop translocation in vivo was comparable to the results from the ex vivo MLN cultures. The highest percentage of Yop+ cells were among CD11b+ cells and Vγ4 T cells. Given
the low MOI used in our ex vivo studies with the WT Yptb-βla reporter and the lack of inhibition observed in Vγ4 T cells that lack Yop effectors from the same culture conditions, it is
likely that intrinsic Yop effects on Vγ4 T cells is a mechanism of inhibiting Vγ4 T cell function
in vivo. Thus, while Y. pseudotuberculosis can use γδ T cell intrinsic mechanisms to subvert the
γδ T cell IFNγ response, multiple mechanisms may be available for Yersinia spp. to subvert γδ
T cell functions to aid pathogenesis in vivo. As we previously demonstrated that foodborne but
not i.v. infection led to adaptive Vγ4 T cell responses [37], our physiologic foodborne Y.
pseudotuberculosis infection model revealed novel aspects of Yersinia pathogenesis and adaptive Vγ4 T cell biology.
In summary, the Y. pseudotuberculosis effector YopJ directly inhibits essential anti-effective
functions of murine Vγ4 T cells and human Vδ2+ T cells. Y. pseudotuberculosis targeted Vγ4 T
cells in a T3SS- and YadA-dependent process to deliver Yop effectors directly into Vγ4 T cells.
Ex vivo whole tissue cultures revealed that direct inhibition of Vγ4 T cell function was the
major mechanism of Vγ4 T cell subversion. YopJ translocation led to a dramatic reduction in
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STAT4 phosphorylation levels and IFNγ production, which is important for protection from
Yersinia. YopJ also inhibited a broad anti-infective gene signature. Thus, these findings add
substantial insight into YopJ effector functions on murine and human γδ T cells and the pathogenesis of foodborne Y. pseudotuberculosis infection.

Materials and methods
Ethics statement
All animal experiments were conducted in accordance with the Stony Brook University Institutional Animal Care and Use Committee and National Institutes of Health guidelines. Blood
collection from healthy human donors was approved by the Institutional Review Board at
Stony Brook University.

Mice
Female 8–12 week old BALB/cJ mice were purchased from the Jackson Laboratory. Mice were
euthanized by CO2 inhalation.

Human studies
Blood was sampled from a total of 6 adult healthy human donors of either gender between the
ages of 20 and 40. Studies were designed so no randomization to experimental groups was necessary. Donors provided written informed consent.

Bacteria
Bacteria strains used in this study include: Y. pseudotuberculosis on the 32777 background WT
strain, WT32777c, YopJC172A, YopHR409A, ΔYopB, YopER144A, YopTC139A, ΔYopM, ΔYpkA,
ΔYopK, WT Yptb-βla, and ΔYopB Yptb-βla. Y. pseudotuberculosis on the IP2666 background
WT strain, ΔYopB, ΔInv, ΔYadA, ΔInv ΔYadA, and ΔYopB ΔInv ΔYadA. See Table 1 for
details. All strains were stored in 25% glycerol stocks at -80˚C. For stimulations, Y. pseudotuberculosis strains were cultured overnight at 28˚C and 220 RPM in LB media. The following
morning, Y. pseudotuberculosis was sub-cultured 1:10 in LB and 50 mM CaCl2 at 37˚C and 220
RPM for approximately 2 hours. Stimulation doses were based on the OD600.

Foodborne L. monocytogenes immunization
L. monocytogenes (EGDe strain) expressing a mutation in the internalin A gene (InlAM) was
used for foodborne infection to facilitate epithelial cell invasion [117]. InlAM L. monocytogenes
was cultured overnight at 37˚C and 220 RPM in BHI media. The following morning, L. monocytogenes was sub-cultured 1:10 in BHI at 37˚C and 220 RPM for approximately 2 hours. Infection doses were based on the OD600. Mice were food and water deprived for 4 hours.
Approximately 0.5 cm3 bread pieces were inoculated with 2x109 CFU L. monocytogenes in
50 μL. Mice were monitored to ensure the inoculated bread was consumed within 1 hour.
Mice that did not fully consume bread were removed from the study. Bacterial infection doses
were confirmed by plating inoculum on BHI.

Foodborne Y. pseudotuberculosis infection
Y. pseudotuberculosis strains (Table 1) were cultured overnight at 28˚C and 220 RPM in LB
media. Infection doses were based on the OD600. Mice were food and water deprived for 4
hours. Approximately 0.5 cm3 bread pieces were inoculated with 2-4x107 CFU for WT32777
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Y. pseudotuberculosis, 2-4x107–2-4x108 CFU for YopJC172A Y. pseudotuberculosis, or 2x109
CFU for WT Yptb-βla infection in 50 μL. Mice were monitored to ensure the inoculated bread
was consumed within 1 hour. Mice that did not fully consume bread were removed from the
study. Bacterial infection doses were confirmed by plating inoculum on LB.

Single cell preparations, Y. pseudotuberculosis stimulations, and flow
cytometry
MLN from L. monocytogenes immunized mice were harvested 9 days after immunization and
mechanically dissociated using a syringe plunger through a 70 μm cell strainer into a single
cell suspension. Cells were resuspended in IMDM (Gibco) supplemented with 10% fetal
bovine serum, 0.01 M HEPES, 100 μM non-essential amino acids (Gibco), 2 mM L-alanyl-Lglutamine dipeptide in 0.85% NaCl or 1x Glutamax (Gibco), and 1 mM sodium pyruvate.
Cells were counted using a Vi-CELL Viability Analyzer (Beckman Coulter). Cells were stimulated in 96 well round-bottom tissue culture treated plates with various strains of Y. pseudotuberculosis at 1 or 10 MOI (1 MOI for WT or ΔYopB Yptb-βla and 10 MOI for all other Y.
pseudotuberculosis stimulations, unless otherwise indicated) at 37˚C/5% CO2. 100 U/mL of
penicillin and 100 μg/mL of streptomycin were added to cells 2 hours post-stimulation. Cells
were stimulated for a total of 24 hours or as indicated. BD GolgiPlug (BD Biosciences) was
added 5 hours prior to the end of stimulation. If translocation was assessed, β-lactamase Loading Solutions kit (Invitrogen) was used to load CCF4-AM by incubating CCF4-AM at RT with
cells for 1 hour in the dark. Cells were then processed for surface staining via incubation with
live/dead stain, antibody, and Fc block (BioXcell) for 20 min in the dark at 4˚C. Antibodies
used included antibodies specific to CD45, CD3, TCRδ, CD8, CD4, Vγ1.1, Vγ2, CD44, CD27,
F4/80, CD11b, MHCII, CD11c, and CD29 (BioLegend). Cells were fixed, permeabilized, and
stained with anti-IFNγ, anti-IRF8, or anti-STAT4 using BD Cytofix/Cytoperm kit (BD Biosciences) for intracellular cytokine staining. Functional γδ T cell analysis was done by stimulation
with BD leukocyte activation cocktail (containing PMA, ionomycin, and brefeldin A; BD
Pharmingen) for 4 hours prior to staining. Flow cytometry data were acquired using a BD
LSRFortessa and analyzed by FlowJo software (BD Biosciences). Cell culture supernatant was
analyzed for IL-12p70 using the BioLegend ELISA MAX Deluxe Set Mouse IL-12 (p70) kit per
manufacturer instructions.

Human γδ T cell response
Blood was drawn and collected from healthy human donors in BD Vacutainer sodium heparin
tubes (BD Biosciences). Blood was diluted 1:1 with 1x PBS at room temperature. Peripheral
blood mononuclear cells (PBMC) were isolated from the buffy coat of Ficoll-paque PLUS gradient centrifugation (GE Healthcare) for 20 min at 1,400 × g without a brake. PBMC were
washed with 1x PBS at room temperature and resuspended in IMDM supplemented with 10%
fetal bovine serum, 0.01 M HEPES, 100 μM Non-essential amino acids (Gibco), 2 mM L-alanyl-L-glutamine dipeptide in 0.85% NaCl or 1x Glutamax (Gibco), and 1 mM sodium pyruvate. Y. pseudotuberculosis strains were cultured overnight at 28˚C and 220 RPM in LB media
the night prior. The following morning, Y. pseudotuberculosis was sub-cultured 1:10 in LB and
50 mM CaCl2 at 37˚C and 220 RPM for approximately 2 hours. Stimulation doses were based
on the OD600. Cells were counted using a Vi-CELL Viability Analyzer (Beckman Coulter).
Cells were stimulated in 96 round-bottom tissue culture treated plates with various strains of
Y. pseudotuberculosis at 1 MOI at 37˚C/5% CO2. 1x penicillin and streptomycin (100 U/mL
penicillin and 100 μg/mL streptomycin) were added to cells 2 hours post-stimulation. Cells
were stimulated for a total of 24 hours or as indicated. BD GolgiPlug (BD Biosciences) was
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added 5 hours prior to the end of stimulation. If translocation was assessed, β-lactamase Loading Solutions kit (Invitrogen) was used to load CCF4-AM by incubating CCF4-AM at RT with
cells for 1 hour in the dark. Cells were then processed for surface staining via incubation with
live/dead stain, antibody, and Fc block (BioXcell) for 20 min in the dark at 4˚C. Antibodies
used included antibodies specific to Vδ2, CD3, TCRδ, (BioLegend). Cells were fixed, permeabilized, and stained with anti-IFNγ using BD Cytofix/Cytoperm kit (BD Biosciences) for intracellular cytokine staining. Flow cytometry data were acquired using a BD LSRFortessa and
analyzed by FlowJo software (BD Biosciences).

Phospho-flow cytometry
After surface staining for flow cytometry, cells were washed and stained for pSTAT4 using a
methanol-based approach. Cells were fixed in 4% PFA/1.5% methanol for 30 minutes in the
dark at 4˚C. Cells were then washed and incubated in methanol in the dark at 20˚C for 45 minutes. After washing, cells were stained with anti-pSTAT4 (Y693)-PE (BD Biosciences) and
washed once more. Flow cytometry data were acquired using a BD LSRFortessa and analyzed
by FlowJo software (BD Biosciences).

Enumeration of Y. pseudotuberculosis burden
MLN were crushed and diluted in media prior to plating on LB agar. Total Y. pseudotuberculosis burden per organ was calculated.

Sequencing and analysis
Samples were prepared after Y. pseudotuberculosis stimulation as described above. Cell preparations were stimulated with 10 MOI of WT or YopJC172A Y. pseudotuberculosis or 1 MOI of
WT Yptb-βla for 24 hours. 500 Vγ1.1/2- CD44hi CD27- γδ T cells were flow sorted directly into
a tube with NEBNext Cell Lysis Buffer and Murine RNase Inhibitor and processed for RNA
sequencing using NEBNext Single Cell/Low Input RNA Library Prep Kit (Illumina). Sequencing was performed at the Cold Spring Harbor Laboratory sequencing core on a NextSeq500.
Fastq files were produced as an output of the sequencing files. Fastq were run through FastQC
to perform quality control of transcripts prior to alignment. Fastq files were pair-ended aligned
to GRCm38/mm10 by way of HISAT2 and output as .BAM files [118]. Raw counts of aligned
transcripts were quantified with FeatureCounts [119]. Dimensionality reduction was performed with PCA analysis with the axes PC1 and PC2 in R-studio [120]. To determine differential expression between samples, FeatureCounts raw count matrix was analyzed through
DESeq2 with a parametric fitting normalized to the geometric mean of each individual gene
across samples [121]. Cutoff values for significance and quality control were a p-value of <0.05
and FDR-value of <0.10, respectively. Significantly differentially expressed genes were visualized on a heatmap with a dendrogram that was clustered through average linkage. The distance
measurement on the dendrogram used was through the Euclidean method. Overlapping
expressions between gene differential expression sets were filtered with R-studio. Upregulated
and downregulated genes from the differential expression analysis were separated with R-studio and these Gene IDs were used for HOMER motif analysis [74]. Parameters of analysis of
each gene used were 400bp preceding the initiation site and 100bp after the initiation site. The
length of the motifs analyzed was set between 8 and 10.
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γδ T cell purification
γδ T cells were expanded in vitro according to published protocols [122]. The MLN and spleen
were isolated and processed into a single cell suspension 9 days post foodborne L. monocytogenes infection of Balb/c mice. Red blood cells were lysed with red blood cell lysis buffer or
ammonium chloride for 1 minute and cells from the MLN and spleen were combined. γδ T
cells were enriched by negative selection using the following rat IgG primary antibodies from
BioLegend: anti-CD4 (clone GK1.5), anti-CD8α (clone 53–6.7), anti-B220 (clone RA3-6B2),
anti-MHC-II (clone M5/114.15.2), and anti-CD11b (clone M1/70). The MACS goat anti-rat
IgG kit (Miltenyi Biotec) was used per manufacturer instructions with MACS LD columns
and a QuadroMACS magnet. Enriched cells were cultured in 48-well plates coated overnight
with 5 ug/ml anti-TCRδ (clone GL3). Cells were cultured in RPMI 1640 supplemented with 25
mM HEPES (Gibco), 1x glucose (Gibco), 10 g/ml folate (Sigma Aldrich), 1x sodium pyruvate
(Gibco), 5x105 M 2 beta-mercaptoethanol (Sigma Aldrich), 1x Glutamax (Gibco), 1x penicillin-streptomycin (Gibco), and 10% FBS with 100 U/ml recombinant human IL-2. After 2 days
of culture, cells were transferred into new wells with the same culture media to rest for 5 days.
Cells were then stimulated with 10 MOI YopJC172A Y. pseudotuberculosis with 0.1, 1, or 10 ng/
ml of recombinant murine IL-12p70 (Peprotech).

In vivo anti-IL-12p40 antibody treatment and serum collection
On the day of foodborne WT or YopJC172A Y. pseudotuberculosis infection and on day 2, 4,
and 6 after infection, mice were treated with 0.2 mg of anti-IL-12p40 (clone C17.8; BioLegend)
by i.p. injection. Blood was collected via tail vein on day 2, 4, and 6 after infection. Blood was
incubated at ambient temperature for 30 minutes before being spun down at 1500G for 10
minutes at 4˚C. Serum was isolated and analyzed for IL-12p70 with the BioLegend ELISA
MAX Deluxe Set Mouse IL-12 (p70) kit.

Ex vivo anti-IL-12p40 and recombinant IL-12p70 treatments
At the start of Y. pseudotuberculosis stimulation of MLN cell suspensions, cultures were treated
with 10 μg/ml anti-IL-12p40 (clone C17.8; BioLegend) for neutralization. In other conditions,
recombinant murine IL-12p70 (Peprotech) was added at the start of Y. pseudotuberculosis
stimulation of MLN cell suspensions at 2, 10, or 50 ng/ml.

Statistical analysis
GraphPad Prism 6 software (GraphPad Software Inc.) was used for statistical analysis. The differences between the means were compared using the statistical analysis described in the associated figure legends. All the data are presented as mean ± SEM and p < 0.05 was considered
significant. � p < 0.05, �� p < 0.01, ��� p < 0.001, ���� p < 0.0001.

Supporting information
S1 Data. Excel spreadsheet containing the underlying numerical data for Figs 1A–1C, 2A
and 2B, 3A, 5A–5D and 6A–6F.
(XLSX)
S1 Fig. Use of the Yptb-βla reporter to track Yop translocation. (A) MLN suspensions from
L. monocytogenes infected mice were stimulated with WT or ΔYopB Y. pseudotuberculosis containing a β-lactamase translocation reporter (Yptb-βla) for 2 hours and given antibiotics. Cells
were loaded with CCF4-AM dye to measure β-lactamase activity. FITC indicates CCF4-AM
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loaded cells without translocation (Yop-) and BV421 indicates CCF4-AM loaded cells with
Yop translocation (Yop+). Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for Yop translocation 2 hours post stimulation at an MOI of 10. Representative contour plots are displayed. (B)
MLN from L. monocytogenes infected mice were stimulated with Yptb-βla for 2 hours and
given antibiotics. Yop translocation was detected as described above. The indicated cell populations were analyzed for Yop translocation 2 hours after stimulation. Representative contour
plots are displayed. (C) MLN from L. monocytogenes infected mice were stimulated with Yptbβla for 2 hours and given antibiotics. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for Yop
translocation 2 hours post stimulation at the indicated MOI and quantified for Yop translocation. Data consists of one experiment with 2–10 mice/group and the graphs depict the
mean ± SEM in (A-C). ���� p < 0.0001, ��� p < 0.001, and �� p < 0.01. A t-test was used for (A),
and a repeated measures one-way ANOVA was used for (C). Comparisons were performed to
ΔYopB Y. pseudotuberculosis in (A) and as depicted in (C).
(TIF)
S2 Fig. The majority of Vγ1.1/2- CD44hi CD27- γδ T cells and γδ T cells containing Yop
express β1-integrin. (A) MLN from L. monocytogenes infected mice were isolated and processed into single cell suspensions. Vγ1.1/2- CD44hi CD27- γδ T cells, CD4 T cells, and CD8 T
cells were analyzed for β1-integrin expression. (B) MLN suspensions from L. monocytogenes
infected mice were loaded with CCF4-AM dye and stimulated with 10 MOI WT Y. pseudotuberculosis containing a β-lactamase translocation reporter. CCF4-AM dye reports the occurrence of β-lactamase activity and Yop translocation. γδ T cells that contain Yop (Yop+) or do
not contain Yop (Yop-) were analyzed for β1-integrin expression 2 hours after stimulation.
Representative histogram plots are displayed. Data is pooled from two experiments with a total
of 7 mice/group and the graphs depict the mean ± SEM in (A-C). ���� p < 0.0001 and
���
p < 0.001. A repeated measures one-way ANOVA was used for (A) and a t-test was used
for (B), and. Comparisons were done to adaptive γδ T cells in (A) and as depicted in (B).
(TIF)
S3 Fig. YopJ regulates the transcriptional profile of Vγ1.1/2- CD44hi CD27- γδ T cells. (A
and B) MLN from L. monocytogenes infected mice were stimulated with 10 MOI of WT Y.
pseudotuberculosis (WT) or mutant YopJ Y. pseudotuberculosis (YopJC172A) for 24 hours. Antibiotics were given 2 hours post-stimulation. Five hundred Vγ1.1/2- CD44hi CD27- γδ T cells
from each stimulation were flow sorted and processed for RNA sequencing. The heat map
depicts upregulated genes in Vγ1.1/2- CD44hi CD27- γδ T cells after YopJC172A Y. pseudotuberculosis stimulation and individual genes are listed. (C-E) Genes differentially expressed (downregulated) that overlapped between RNA sequencing analyses as displayed in the Venn
diagram in (C) to select for direct effects of YopJ on Vγ1.1/2- CD44hi CD27- γδ T cells. The
heat map depicts downregulated genes in Vγ1.1/2- CD44hi CD27- γδ T cells from the analysis
in (C). Individual genes are listed in (E). Each experiment was performed once with biologic
replicates. The cutoff for gene significance was p < 0.05 and FDR < 0.10.
(TIF)
S4 Fig. YopJ does not inhibit IL-17A production in Vγ1.1/2- CD44hi CD27- γδ T cells.
MLN cell suspensions from L. monocytogenes infected mice were stimulated with 10 MOI of
WT, YopJC172A, or ΔYopB Y. pseudotuberculosis for 24 hours. Antibiotics were given 2 hours
after stimulation and brefeldin A was added for the last 5–6 hours. Vγ1.1/2- CD44hi CD27- γδ
T cells were analyzed for IL-17A production after stimulation. Representative histograms are
displayed. The graph depicts mean ± SEM and represents two independent experiments with
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4 mice per group. A repeated measures one-way ANOVA was used. � p < 0.05.
(TIF)
S5 Fig. YopJ impacts IFNγ related transcription factor motifs but not STAT4 protein. (A)
Homer motif analysis was performed on the RNA sequencing results for the YopJC172A and
WT Y. pseudotuberculosis comparison from Fig 5. The panel highlights the top transcription
factor motifs of the ETS, SP/KLF, and IRF family of proteins identified in YopJC172A stimulated
Vγ1.1/2- CD44hi CD27- γδ T cells. (B) MLN from L. monocytogenes infected mice were stimulated with 10 MOI of WT, YopJC172A, or ΔYopB Y. pseudotuberculosis for 6 hours. Antibiotics
were given 2 hours post-stimulation. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for IRF8
levels with or without anti-IL12p40 neutralizing antibody. The graph depicts the percentage of
IRF8 protein expression among Vγ1.1/2- CD44hi CD27- γδ T cells after WT, YopJC172A, or
ΔYopB Y. pseudotuberculosis stimulation. Data depict two pooled experiments with a total of 8
mice/group and represents the mean ± SEM. (C) The genes from the RNAseq and Homer
motif analysis in Figs 4F and 4G and S3B and S5A were compared to an existing STAT4 ChIPon-chip dataset to identify common genes. Genes from our dataset that were represented in
the top 1000 genes of the Chip-on-chip dataset are displayed. (D) STAT4 KO spleens are
shown in maroon and WT spleens are shown in black in representative histograms. The graph
depicts the MFI of STAT4 protein expression in bulk γδ T cells. Data depicts one experiment
with 4 mice/group and represents the mean ± SEM. ���� p < 0.0001, ��� p < 0.001, �� p < 0.01,
�
p < 0.05. A repeated measures one-way ANOVA was used for (B), and a t-test was used for
(D). Comparisons were performed as depicted in (B) and to Naïve WT in (D).
(TIF)
S6 Fig. IL-12 is insufficient to induce IFNγ and does not readily overcome the inhibition of
YopJ. (A) γδ T cells enriched from the MLN and spleen of L. monocytogenes infected mice
were expanded with plate bound γδTCR antibody for 2 days and rested for 5 days. After
expansion, ~ 50% of cells were γδ T cells, and the majority of those were Vγ4 T cells. The
enrichment summary reflects the mean enrichment from 4 samples. Afterwards, γδ T cells
were isolated from cultures and stimulated with YopJC172A Y. pseudotuberculosis with 0.1, 1, or
10 ng/ml IL-12p70 for 24 hours. Antibiotics were added 2 hours after stimulation and brefeldin A was added for the last 5–6 hours. Histograms display IFNγ production from Vγ1.1/2CD44hi CD27- γδ T cells under different culture conditions. Data depicts one experiment with
4 mice pooled and split into the indicated stimulation conditions. (B) MLN cell suspensions
from L. monocytogenes infected mice were stimulated with 10 MOI of WT Y. pseudotuberculosis in the presence of 2, 10, or 50 ng/ml IL-12p70 or 10 MOI of YopJC172A Y. pseudotuberculosis
for 24 hours. Antibiotics were given 2 hours after stimulation and brefeldin A was added for
the last 5–6 hours. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed for IFNγ production. Representative histograms of IFNγ production from Vγ1.1/2- CD44hi CD27- γδ T cells are displayed. The graph depicts mean ± SEM from one experiment with 4 mice per group � p < 0.05.
A repeated measures one-way ANOVA was used for comparisons to YopJC172A Y. pseudotuberculosis in (B).
(TIF)
S7 Fig. The impact of foodborne infection of mice with Y. pseudotuberculosis. (A) Balb/c
mice were foodborne infected with the indicated doses of WT or mutant YopJC172A Y. pseudotuberculosis and tissues were analyzed 9 days post-infection. Bacteria burden was quantified
from the MLN. Data reflect 3–5 mice per group pooled from 3 independent experiments and
the graphs depict the mean ± SEM. (B) Balb/c mice were foodborne infected with the indicated
doses of WT or mutant YopJC172A Y. pseudotuberculosis. Nine days post infection, MLN
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suspensions from WT or YopJC172A Y. pseudotuberculosis infected mice were stimulated with
PMA/ionomycin and brefeldin A for 4 hours. Vγ1.1/2- CD44hi CD27- γδ T cells were analyzed
for IFNγ production. Representative histograms are displayed and quantified. Data depicts
one experiment with 3 mice per group. (C) Balb/c mice were foodborne infected with WT (24x107 CFU) or YopJC172A Y. pseudotuberculosis (2-4x108 CFU) and treated with 0.2 mg/mouse
of anti-IL12p40 on days 0, 2, 4, and 6 post infection. IL-12p70 concentrations were determined
from serum at days 2, 4, and 6 post infection. Data represent 2 independent experiments with
a total of 9 mice per group. Serum samples were pooled into groups of 3 per experimental condition. (D) Balb/c mice were foodborne infected with 2x109 CFU L. monocytogenes to elicit a
Vγ1.1/2- CD44hi CD27- γδ T cell population in vivo. 30 days post infection, adaptive Vγ1.1/2CD44hi CD27- γδ T cells from the MLN of immune mice were analyzed for Yop translocation
using the CCF4-AM assay. Representative contour plots are shown. Yop translocation (Yop+)
among the indicated populations represents background staining as a negative control for Fig
6F. The graph depicts the mean ± SEM and is pooled from 2 experiments with a total of 4 mice
per group. ���� p < 0.0001, � p < 0.05. A one-way ANOVA was used for (A), and an unpaired
t-test was used for (B). Comparisons were performed to uninfected in (A) and to 5x107 WT Y.
pseudotuberculosis in (B).
(TIF)
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